Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA.
J Immunol. 2011 Nov 15;187(10):5392-401. doi: 10.4049/jimmunol.1101288. Epub 2011 Oct 17.
In congenital heart block (CHB), binding of maternal anti-SSA/Ro Abs to fetal apoptotic cardiocytes impairs their removal by healthy cardiocytes and increases urokinase plasminogen activator (uPA)/uPA receptor (uPAR)-dependent plasmin activation. Because the uPA/uPAR system plays a role in TGF-β activation, we evaluated whether anti-Ro binding to apoptotic cardiocytes enhances plasmin-mediated activation of TGF-β, thereby promoting a profibrosing phenotype. Supernatants from cocultures of healthy cardiocytes and apoptotic cardiocytes bound by IgG from a mother whose child had CHB (apoptotic-CHB-IgG [apo-CHB-IgG]) exhibited significantly increased levels of active TGF-β compared with supernatants from cocultures of healthy cardiocytes and apoptotic cardiocytes preincubated with IgG from a healthy donor. Treatment of the culture medium with anti-TGF-β Ab or TGF-β inhibitor (SB431542) abrogated the luciferase response, thereby confirming TGF-β dependency. Increased uPA levels and activity were present in supernatants generated from cocultures of healthy cardiocytes and apo-CHB-IgG cardiocytes compared with healthy cardiocytes and apoptotic cardiocytes preincubated with IgG from a healthy donor, respectively. Treatment of apo-CHB-IgG cardiocytes with anti-uPAR or anti-uPA Abs or plasmin inhibitor aprotinin prior to coculturing with healthy cardiocytes attenuated TGF-β activation. Supernatants derived from cocultures of healthy cardiocytes and apo-CHB-IgG cardiocytes promoted Smad2 phosphorylation and fibroblast transdifferentiation, as evidenced by increased smooth muscle actin and collagen expression, which decreased when fibroblasts were treated with supernatants from cocultures pretreated with uPAR Abs. These data suggested that binding of anti-Ro Abs to apoptotic cardiocytes triggers TGF-β activation, by virtue of increasing uPAR-dependent uPA activity, thus initiating and amplifying a cascade of events that promotes myofibroblast transdifferentiation and scar.
在先天性心脏传导阻滞 (CHB) 中,母体抗 SSA/Ro Ab 与胎儿凋亡心肌细胞结合,损害健康心肌细胞对其的清除,并增加尿激酶纤溶酶原激活物 (uPA)/uPA 受体 (uPAR) 依赖性纤溶酶激活。由于 uPA/uPAR 系统在 TGF-β 激活中发挥作用,我们评估了抗 Ro 与凋亡心肌细胞的结合是否增强了纤溶酶介导的 TGF-β 激活,从而促进了成纤维细胞的转化。与用来自健康供体 IgG 预孵育的健康心肌细胞和凋亡心肌细胞的共培养物上清液相比,来自与来自患有 CHB 儿童的母亲的 IgG 结合的凋亡-CHB-IgG (apo-CHB-IgG) 共培养物的上清液中,活性 TGF-β 的水平显著升高。用抗 TGF-β Ab 或 TGF-β 抑制剂 (SB431542) 处理培养基可消除荧光素酶反应,从而证实了 TGF-β 的依赖性。与用来自健康供体的 IgG 预孵育的健康心肌细胞和凋亡心肌细胞的共培养物相比,来自与 apo-CHB-IgG 心肌细胞共培养物的上清液中 uPA 水平和活性均增加。在用 aprotinin 或抗 uPAR 或抗 uPA Abs 预处理 apo-CHB-IgG 心肌细胞后,再与健康心肌细胞共培养,可减轻 TGF-β 的激活。与 apo-CHB-IgG 心肌细胞共培养的上清液可促进 Smad2 磷酸化和成纤维细胞转分化,表现为平滑肌肌动蛋白和胶原蛋白表达增加,当用用预处理 uPAR Abs 的共培养物上清液处理成纤维细胞时,这种增加会减少。这些数据表明,抗 Ro Ab 与凋亡心肌细胞的结合通过增加 uPAR 依赖性 uPA 活性触发 TGF-β 激活,从而启动和放大一系列促进肌成纤维细胞转分化和瘢痕形成的事件。